Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Video Abstracts
Reviews
Reviews
View all reviews ...
Review Series
Complement Biology and Therapeutics (May 2025)
Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
Microbiome in Health and Disease (Feb 2025)
Substance Use Disorders (Oct 2024)
Clonal Hematopoiesis (Oct 2024)
Sex Differences in Medicine (Sep 2024)
Vascular Malformations (Apr 2024)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Editor's notes
Reviews
Viewpoints
100th anniversary
Top read articles
Citations to this article
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Jay D. Horton, … , Joseph L. Goldstein, Michael S. Brown
Jay D. Horton, … , Joseph L. Goldstein, Michael S. Brown
Published May 1, 2002
Citation Information:
J Clin Invest.
2002;
109(9)
:1125-1131.
https://doi.org/10.1172/JCI15593
.
View:
Text
|
PDF
Spotlight
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Text
PDF
Abstract
Authors
Jay D. Horton, Joseph L. Goldstein, Michael S. Brown
×
Total citations by year
Year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
1989
Total
Citations:
74
133
151
159
139
159
131
116
126
129
109
101
91
98
73
83
72
52
33
26
23
18
16
10
1
2123
Advertisement
Blogged by
2
Referenced in
1
policy sources
Posted by
1
X users
Referenced in
35
patents
Referenced in
3
Wikipedia pages
793
readers on Mendeley
3
readers on CiteULike
See more details